Your browser doesn't support javascript.
loading
Genomic epidemiology of SARS-CoV-2 spread in Scotland highlights the role of European travel in COVID-19 emergence
Ana Da Silva Filipe; James Shepherd; Thomas Williams; Joseph Hughes; Elihu Aranday-Cortes; Patawee Asamaphan; Carlos Balcazar; Kirstyn Brunker; Stephen Carmichael; Rebecca Dewar; Michael D Gallagher; Rory Gunson; Antonia Ho; Natasha Jesudason; Natasha Johnson; E. Carol McWilliam Leitch; Kathy Li; Alasdair MacLean; Daniel Mair; Sarah E. McDonald; Martin McHugh; Jenna Nichols; Marc Niebel; Kyriaki Nomikou; Richard J. Orton; Aine O'Toole; Massimo Palmarini; Yasmin A. Parr; Andrew Rambaut; Stefan Rooke; Sharif Shaaban; Rajiv Shah; Joshua B. Singer; Katherine Smollett; Igor Starinskij; Lily Tong; Vattipally B. Sreenu; Elizabeth Wastnedge; David L. Robertson; Matthew T.G. Holden; Kate Templeton; Emma C. Thomson.
Affiliation
  • Ana Da Silva Filipe; MRC-University of Glasgow Centre for Virus Research
  • James Shepherd; MRC-University of Glasgow Centre for Virus Research
  • Thomas Williams; Institute of Evolutionary Biology, University of Edinburgh
  • Joseph Hughes; MRC-University of Glasgow Centre for Virus Research
  • Elihu Aranday-Cortes; MRC-University of Glasgow Centre for Virus Research
  • Patawee Asamaphan; MRC-University of Glasgow Centre for Virus Research
  • Carlos Balcazar; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh
  • Kirstyn Brunker; MRC-University of Glasgow Centre for Virus Research
  • Stephen Carmichael; MRC-University of Glasgow Centre for Virus Research
  • Rebecca Dewar; Virology Department, Royal Infirmary of Edinburgh
  • Michael D Gallagher; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh
  • Rory Gunson; West of Scotland Specialist Virology Centre, NHSGGC
  • Antonia Ho; MRC-University of Glasgow Centre for Virus Research
  • Natasha Jesudason; MRC-University of Glasgow Centre for Virus Research
  • Natasha Johnson; MRC-University of Glasgow Centre for Virus Research
  • E. Carol McWilliam Leitch; MRC-University of Glasgow Centre for Virus Research
  • Kathy Li; MRC-University of Glasgow Centre for Virus Research
  • Alasdair MacLean; West of Scotland Specialist Virology Centre, NHSGGC
  • Daniel Mair; MRC-University of Glasgow Centre for Virus Research
  • Sarah E. McDonald; MRC-University of Glasgow Centre for Virus Research
  • Martin McHugh; Virology Department, Royal Infirmary of Edinburgh & University of St. Andrews
  • Jenna Nichols; MRC-University of Glasgow Centre for Virus Research
  • Marc Niebel; MRC-University of Glasgow Centre for Virus Research
  • Kyriaki Nomikou; MRC-University of Glasgow Centre for Virus Research
  • Richard J. Orton; MRC-University of Glasgow Centre for Virus Research
  • Aine O'Toole; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh
  • Massimo Palmarini; MRC-University of Glasgow Centre for Virus Research
  • Yasmin A. Parr; MRC-University of Glasgow Centre for Virus Research
  • Andrew Rambaut; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh
  • Stefan Rooke; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh
  • Sharif Shaaban; Public Health Scotland
  • Rajiv Shah; MRC-University of Glasgow Centre for Virus Research
  • Joshua B. Singer; MRC-University of Glasgow Centre for Virus Research
  • Katherine Smollett; MRC-University of Glasgow Centre for Virus Research
  • Igor Starinskij; West of Scotland Specialist Virology Centre, NHSGGC
  • Lily Tong; MRC-University of Glasgow Centre for Virus Research
  • Vattipally B. Sreenu; MRC-University of Glasgow Centre for Virus Research
  • Elizabeth Wastnedge; Virology Department, Royal Infirmary of Edinburgh
  • David L. Robertson; MRC-University of Glasgow Centre for Virus Research
  • Matthew T.G. Holden; Public Health Scotland & University of St. Andrews
  • Kate Templeton; Virology Department, Royal Infirmary of Edinburgh
  • Emma C. Thomson; MRC-University of Glasgow Centre for Virus Research
Preprint in English | medRxiv | ID: ppmedrxiv-20124834
ABSTRACT
SARS-CoV-2, the causative agent of COVID-19, emerged in Wuhan, China in December 2019 and spread rapidly throughout the world. Understanding the introductions of this new coronavirus in different settings may assist control efforts and the establishment of frameworks to support rapid response in future infectious disease outbreaks. We investigated the first four weeks of emergence of the SARS-CoV-2 virus in Scotland after the first case reported on the 1st March 2020. We obtained full genome sequences from 452 individuals with a laboratory-confirmed diagnosis of COVID-19, representing 20% of all cases until 1st April 2020 (n=2310). This permitted a genomic epidemiology approach to study the introductions and spread of the SARS-2 virus in Scotland. From combined phylogenetic and epidemiological analysis, we estimated at least 113 introductions of SARS-CoV-2 into Scotland during this period. Clusters containing multiple sequences suggestive of onward transmission occurred in 48/86 (56%). 42/86 (51%) clusters had no known international travel history indicating undetected introductions. The majority of viral sequences were most closely related to those circulating in other European countries, including Italy, Austria and Spain. Travel-associated introductions of SARS-CoV-2 into Scotland predated travel restrictions in the UK and other European countries. The first local transmission occurred three days after the first case. A shift from travel-associated to sustained community transmission was apparent after only 11 days. Undetected introductions occurred prior to the first known case of COVID-19. Earlier travel restrictions and quarantine measures might have resulted in fewer introductions into Scotland, thereby reducing the number of cases and the subsequent burden on health services. The high number of introductions and transmission rates were likely to have impacted on national contact tracing efforts. Our results also demonstrate that local real-time genomic epidemiology can be used to monitor transmission clusters and facilitate control efforts to restrict the spread of COVID-19. FundingMRC (MC UU 1201412), UKRI/Wellcome (COG-UK), Wellcome Trust Collaborator Award (206298/Z/17/Z - ARTIC Network; TCW Wellcome Trust Award 204802/Z/16/Z Research in contextO_ST_ABSEvidence before this studyC_ST_ABSCoronavirus disease-2019 (COVID-19) was first diagnosed in Scotland on the 1st of March 2020 following the emergence of the causative severe acute respiratory system coronavirus 2 (SARS-CoV-2) virus in China in December 2019. During the first month of the outbreak in Scotland, 2310 positive cases of COVID-19 were detected, associated with 1832 hospital admissions, 207 intensive care admissions and 126 deaths. The number of introductions into Scotland and the source of those introductions was not known prior to this study. Added value of this studyUsing a combined phylogenetic and epidemiological approach following real-time next generation sequencing of 452 SARS-CoV-2 samples, it was estimated that the virus was introduced to Scotland on at least 113 occasions, mostly from other European countries, including Italy, Austria and Spain. Localised outbreaks occurred in the community across multiple Scottish health boards, within healthcare facilities and an international conference and community transmission was established rapidly, before local and international lockdown measures were introduced.
License
cc_no
Full text: Available Collection: Preprints Database: medRxiv Type of study: Observational study / Prognostic study Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Observational study / Prognostic study Language: English Year: 2020 Document type: Preprint
...